Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Chromecki Thomas |

** = Publications listed in SCI/SSCI/Pubmed

2019

Full paper/article (Journal)

** Mischinger, J; Fröhlich, E; Mannweiler, S; Meindl, C; Absenger-Novak, M; Hutterer, GC; Seles, M; Augustin, H; Chromecki, TF; Jesche-Chromecki, J; Pummer, K; Zigeuner, R Prognostic value of B7-H1, B7-H3 and the stage, size, grade and necrosis (SSIGN) score in metastatic clear cell renal cell carcinoma.
Cent European J Urol. 2019; 72(1): 23-31. Doi: 10.5173/ceju.2018.1858 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2016

Full paper/article (Journal)

** Becker, A; Hickmann, D; Hansen, J; Meyer, C; Rink, M; Schmid, M; Eichelberg, C; Strini, K; Chromecki, T; Jesche, J; Regier, M; Randazzo, M; Tilki, D; Ahyai, S; Dahlem, R; Fisch, M; Zigeuner, R; Chun, FK Critical analysis of a simplified Fuhrman grading scheme for prediction of cancer specific mortality in patients with clear cell renal cell carcinoma--Impact on prognosis.
Eur J Surg Oncol. 2016; 42(3):419-25 Doi: 10.1016/j.ejso.2015.09.023
Web of Science PubMed FullText FullText_MUG

 

** Mager, R; Daneshmand, S; Evans, CP; Palou, J; Martínez-Salamanca, JI; Master, VA; McKiernan, JM; Libertino, JA; Haferkamp, A; International Renal Cell Carcinoma-Venous Thrombus Consortium; Haferkamp, A; Capitanio, U; Carballido, JA; Chantada, V; Chromecki, T; Ciancio, G; Daneshmand, S; Evans, CP; Gontero, P; González, J; Hohenfellner, M; Huang, WC; Koppie, TM; Libertino, JA; Espinós, EL; Lorentz, A; Martínez-Salamanca, JI; Master, VA; McKiernan, JM; Montorsi, F; Novara, G; O'Malley, P; Pahernik, S; Palou, J; Moreno, JL; Pruthi, RS; Faba, OR; Russo, P; Scherr, DS; Shariat, SF; Spahn, M; Terrone, C; Tilki, D; Vázquez-Martul, D; Donoso, CV; Vergho, D; Wallen, EM; Zigeuner, R Renal cell carcinoma with inferior vena cava involvement: Prognostic effect of tumor thrombus consistency on cancer specific survival.
J Surg Oncol. 2016; 114(6):764-768 Doi: 10.1002/jso.24395 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Meyer, C; Hansen, J; Becker, A; Schmid, M; Pradel, L; Strini, K; Chromecki, T; Jesche-Chromecki, J; Fisch, M; Zigeuner, R; Chun, FK The Adoption of Nephron-Sparing Surgery in Europe - A Trend Analysis in Two Referral Centers from Austria and Germany.
Urol Int. 2016; 96(3):330-336 Doi: 10.1159/000442215
Web of Science PubMed FullText FullText_MUG

 

2015

Full paper/article (Journal)

** Nguyen, HG; Tilki, D; Dall'Era, MA; Durbin-Johnson, B; Carballido, JA; Chandrasekar, T; Chromecki, T; Ciancio, G; Daneshmand, S; Gontero, P; Gonzalez, J; Haferkamp, A; Hohenfellner, M; Huang, WC; Espinós, EL; Mandel, P; Martinez-Salamanca, JI; Master, VA; McKiernan, JM; Montorsi, F; Novara, G; Pahernik, S; Palou, J; Pruthi, RS; Rodriguez-Faba, O; Russo, P; Scherr, DS; Shariat, SF; Spahn, M; Terrone, C; Vergho, D; Wallen, EM; Xylinas, E; Zigeuner, R; Libertino, JA; Evans, CP Cardiopulmonary Bypass has No Significant Impact on Survival in Patients Undergoing Nephrectomy and Level III-IV Inferior Vena Cava Thrombectomy: Multi-Institutional Analysis.
J Urol. 2015; 194(2):304-308 Doi: 10.1016/j.juro.2015.02.2948 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Tilki, D; Hu, B; Nguyen, HG; Dall'Era, MA; Bertini, R; Carballido, JA; Chandrasekar, T; Chromecki, T; Ciancio, G; Daneshmand, S; Gontero, P; Gonzalez, J; Haferkamp, A; Hohenfellner, M; Huang, WC; Koppie, TM; Linares, E; Lorentz, CA; Mandel, P; Martinez-Salamanca, JI; Master, VA; Matloob, R; McKiernan, JM; Mlynarczyk, CM; Montorsi, F; Novara, G; Pahernik, S; Palou, J; Pruthi, RS; Ramaswamy, K; Rodriguez Faba, O; Russo, P; Shariat, SF; Spahn, M; Terrone, C; Thieu, W; Vergho, D; Wallen, EM; Xylinas, E; Zigeuner, R; Libertino, JA; Evans, CP Impact of synchronous metastasis distribution on cancer specific survival in renal cell carcinoma after radical nephrectomy with tumor thrombectomy.
J Urol. 2015; 193(2):436-442 Doi: 10.1016/j.juro.2014.07.087
Web of Science PubMed FullText FullText_MUG

 

2014

Full paper/article (Journal)

** Aziz, A; May, M; Zigeuner, R; Pichler, M; Chromecki, T; Cindolo, L; Schips, L; De Cobelli, O; Rocco, B; De Nunzio, C; Tubaro, A; Coman, I; Truss, M; Dalpiaz, O; Hoschke, B; Gilfrich, C; Feciche, B; Fenske, F; Sountoulides, P; Figenshau, RS; Madison, K; Sánchez-Chapado, M; Del Carmen Santiago Martin, M; Wieland, WF; Salzano, L; Lotrecchiano, G; Waidelich, R; Stief, C; Brookman-May, S; Members of the CORONA Project and the Young Academic Urologists Renal Cancer Group Do young patients with renal cell carcinoma feature a distinct outcome after surgery? A comparative analysis of patient age based on the multinational CORONA database.
J Urol. 2014; 191(2):310-315 Doi: 10.1016/j.juro.2013.08.021
Web of Science PubMed FullText FullText_MUG

 

** May, M; Zigeuner, R; Aziz, A; Cindolo, L; Gilfrich, C; Schips, L; De Cobelli, O; Rocco, B; De Nunzio, C; Tubaro, A; Coman, I; Feciche, B; Truss, M; Hoschke, B; Dalpiaz, O; Stoltze, A; Fenske, F; Fritsche, HM; Chromecki, T; Lebentrau, S; Figenshau, RS; Madison, K; Sánchez-Chapado, M; Del Carmen Santiago Martin, M; Salzano, L; Lotrecchiano, G; Joniau, S; Waidelich, R; Stief, CG; Brookman-May, S; Mitglieder des "CORONA projects"; Projektgruppe "Young Academic Urologists Renal Cancer Group" der European Association of Urology (EAU) [Postoperative prognosis of chromophobic renal cell carcinoma: comparative analysis of the multinational CORONA database].
Urologe A. 2014; 53(2):228-235 Doi: 10.1007/s00120-013-3237-y
Web of Science PubMed FullText FullText_MUG

 

** Tilki, D; Nguyen, HG; Dall'Era, MA; Bertini, R; Carballido, JA; Chromecki, T; Ciancio, G; Daneshmand, S; Gontero, P; Gonzalez, J; Haferkamp, A; Hohenfellner, M; Huang, WC; Koppie, TM; Lorentz, CA; Mandel, P; Martinez-Salamanca, JI; Master, VA; Matloob, R; McKiernan, JM; Mlynarczyk, CM; Montorsi, F; Novara, G; Pahernik, S; Palou, J; Pruthi, RS; Ramaswamy, K; Rodriguez Faba, O; Russo, P; Shariat, SF; Spahn, M; Terrone, C; Vergho, D; Wallen, EM; Xylinas, E; Zigeuner, R; Libertino, JA; Evans, CP Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus.
Eur Urol. 2014; 66(3):577-583 Doi: 10.1016/j.eururo.2013.06.048
Web of Science PubMed FullText FullText_MUG

 

Review

** Martínez-Salamanca, JI; Linares, E; González, J; Bertini, R; Carballido, JA; Chromecki, T; Ciancio, G; Daneshmand, S; Evans, CP; Gontero, P; Haferkamp, A; Hohenfellner, M; Huang, WC; Koppie, TM; Master, VA; Matloob, R; McKiernan, JM; Mlynarczyk, CM; Montorsi, F; Nguyen, HG; Novara, G; Pahernik, S; Palou, J; Pruthi, RS; Ramaswamy, K; Faba, OR; Russo, P; Shariat, SF; Spahn, M; Terrone, C; Tilki, D; Vergho, D; Wallen, EM; Xylinas, E; Zigeuner, R; Libertino, JA Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC).
Curr Urol Rep. 2014; 15(5):404-404 Doi: 10.1007/s11934-014-0404-7
Web of Science PubMed FullText FullText_MUG

 

2013

Full paper/article (Journal)

** Brookman-May, S; May, M; Ficarra, V; Kainz, MC; Kampel-Kettner, K; Kohlschreiber, S; Wenzl, V; Schneider, M; Burger, M; Wieland, WF; Otto, W; Tilki, D; Gilfrich, C; Hohenfellner, M; Pahernik, S; Chromecki, TF; Stief, C; Zigeuner, R; Members of the CORONA (Collaborative Research On Renal Neoplasms Association) Project Does preoperative platelet count and thrombocytosis play a prognostic role in patients undergoing nephrectomy for renal cell carcinoma? Results of a comprehensive retrospective series.
World J Urol. 2013; 31(5):1309-1316 Doi: 10.1007/s00345-012-0931-0
Web of Science PubMed FullText FullText_MUG

 

** Brookman-May, S; May, M; Shariat, SF; Xylinas, E; Stief, C; Zigeuner, R; Chromecki, T; Burger, M; Wieland, WF; Cindolo, L; Schips, L; De Cobelli, O; Rocco, B; De Nunzio, C; Feciche, B; Truss, M; Gilfrich, C; Pahernik, S; Hohenfellner, M; Zastrow, S; Wirth, MP; Novara, G; Carini, M; Minervini, A; Simeone, C; Antonelli, A; Mirone, V; Longo, N; Simonato, A; Carmignani, G; Ficarra, V; Members of the CORONA project and the SATURN project Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
Eur Urol. 2013; 64(3):472-477 Doi: 10.1016/j.eururo.2012.06.030
Web of Science PubMed FullText FullText_MUG

 

** Brookman-May, S; May, M; Shariat, SF; Zigeuner, R; Chromecki, T; Cindolo, L; Schips, L; De Cobelli, O; Rocco, B; De Nunzio, C; Tubaro, A; Feciche, B; Coman, I; Truss, M; Pahernik, S; Wirth, MP; Zastrow, S; Dalpiaz, O; Fenske, F; Waidelich, R; Stief, C; Gunia, S; Members of the CORONA Project Prognostic effect of sarcomatoid dedifferentiation in patients with surgically treated renal cell carcinoma: a matched-pair analysis.
Clin Genitourin Cancer. 2013; 11(4):465-470 Doi: 10.1016/j.clgc.2013.04.026
Web of Science PubMed FullText FullText_MUG

 

** Chromecki, TF; Cha, EK; Fajkovic, H; Rink, M; Ehdaie, B; Svatek, RS; Karakiewicz, PI; Lotan, Y; Tilki, D; Bastian, PJ; Daneshmand, S; Kassouf, W; Durand, M; Novara, G; Fritsche, HM; Burger, M; Izawa, JI; Brisuda, A; Babjuk, M; Pummer, K; Shariat, SF Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy.
BJU Int. 2013; 111(2):249-255 Doi: 10.1111/j.1464-410X.2012.11322.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Cindolo, L; Chiodini, P; Brookman-May, S; De Cobelli, O; May, M; Squillacciotti, S; De Nunzio, C; Tubaro, A; Coman, I; Feciche, B; Truss, M; Wirth, MP; Dalpiaz, O; Chromecki, TF; Shariat, SF; Sanchez-Chapado, M; Santiago Martin, Mdel C; Rocco, B; Salzano, L; Lotrecchiano, G; Berardinelli, F; Schips, L Assessing the accuracy and generalizability of the preoperative and postoperative Karakiewicz nomograms for renal cell carcinoma: results from a multicentre European and US study.
BJU Int. 2013; 112(5):578-584 Doi: 10.1111/j.1464-410X.2012.11670.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Fajkovic, H; Cha, EK; Jeldres, C; Robinson, BD; Rink, M; Xylinas, E; Chromecki, TF; Breinl, E; Svatek, RS; Donner, G; Tagawa, ST; Tilki, D; Bastian, PJ; Karakiewicz, PI; Volkmer, BG; Novara, G; Joual, A; Faison, T; Sonpavde, G; Daneshmand, S; Lotan, Y; Scherr, DS; Shariat, SF Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.
Eur Urol. 2013; 64(5):837-845 Doi: 10.1016/j.eururo.2012.07.026
Web of Science PubMed FullText FullText_MUG

 

** Hutterer, GC; Pichler, M; Chromecki, TF; Strini, KA; Klatte, T; Pummer, K; Remzi, M; Mannweiler, S; Zigeuner, R Tumour-associated macrophages might represent a favourable prognostic indicator in patients with papillary renal cell carcinoma.
Histopathology. 2013; 63(3):309-315 Doi: 10.1111/his.12163
Web of Science PubMed FullText FullText_MUG

 

** May, M; Aziz, A; Zigeuner, R; Chromecki, T; Cindolo, L; Schips, L; De Cobelli, O; Rocco, B; De Nunzio, C; Tubaro, A; Coman, I; Truss, M; Dalpiaz, O; Hoschke, B; Gilfrich, C; Feciche, B; Stoltze, A; Fenske, F; Fritsche, HM; Figenshau, RS; Madison, K; Sánchez-Chapado, M; Martin, Mdel C; Salzano, L; Lotrecchiano, G; Joniau, S; Waidelich, R; Stief, C; Brookman-May, S; Members of the CORONA project the Young Academic Urologists Renal Cancer Group Gender differences in clinicopathological features and survival in surgically treated patients with renal cell carcinoma: an analysis of the multicenter CORONA database.
World J Urol. 2013; 31(5):1073-1080 Doi: 10.1007/s00345-013-1071-x
Web of Science PubMed FullText FullText_MUG

 

** May, M; Ficarra, V; Shariat, SF; Zigeuner, R; Chromecki, T; Cindolo, L; Burger, M; Gunia, S; Feciche, B; Wenzl, V; Aziz, A; Chun, F; Becker, A; Pahernik, S; Simeone, C; Longo, N; Zucchi, A; Antonelli, A; Mirone, V; Stief, C; Novara, G; Brookman-May, S; CORONA and SATURN projects; Young Academic Urologists Renal Cancer Group Impact of clinical and histopathological parameters on disease specific survival in patients with collecting duct renal cell carcinoma: development of a disease specific risk model.
J Urol. 2013; 190(2):458-463 Doi: 10.1016/j.juro.2013.02.035
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Hutterer, GC; Chromecki, TF; Jesche, J; Kampel-Kettner, K; Groselj-Strele, A; Hoefler, G; Pummer, K; Zigeuner, R Comparison of the 2002 and 2010 TNM classification systems regarding outcome prediction in clear cell and papillary renal cell carcinoma.
Histopathology. 2013; 62(2):237-246 Doi: 10.1111/his.12001
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Hutterer, GC; Chromecki, TF; Jesche, J; Kampel-Kettner, K; Groselj-Strele, A; Pummer, K; Zigeuner, R Predictive ability of the 2002 and 2010 versions of the Tumour-Node-Metastasis classification system regarding metastasis-free, cancer-specific and overall survival in a European renal cell carcinoma single-centre series.
BJU Int. 2013; 111(4 Pt B):E191-E195 Doi: 10.1111/j.1464-410X.2012.11584.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Hutterer, GC; Chromecki, TF; Pummer, K; Mannweiler, S; Zigeuner, R Presence and extent of histological tumour necrosis is an adverse prognostic factor in papillary type 1 but not in papillary type 2 renal cell carcinoma.
Histopathology. 2013; 62(2):219-228 Doi: 10.1111/j.1365-2559.2012.04328.x
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Hutterer, GC; Stoeckigt, C; Chromecki, TF; Stojakovic, T; Golbeck, S; Eberhard, K; Gerger, A; Mannweiler, S; Pummer, K; Zigeuner, R Validation of the pre-treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients.
Br J Cancer. 2013; 108(4):901-907 Doi: 10.1038/bjc.2013.28 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Youssef, RF; Shariat, SF; Lotan, Y; Cost, N; Wood, CG; Sagalowsky, AI; Zigeuner, R; Langner, C; Chromecki, TF; Montorsi, F; Bolenz, C; Margulis, V Urothelial carcinoma at the uretero-enteric junction: multi-center evaluation of oncologic outcomes after radical nephroureterectomy.
Urol Oncol. 2013; 31(5):676-681 Doi: 10.1016/j.urolonc.2011.05.006
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Hutterer, GC; Pichler, M; Stoeckigt, C; Chromecki, TF; Stojakovic, T; Golbeck, S; Mannweiler, S; Pummer, K; Zigeuner, R A LARGE SCALE VALIDATION STUDY PROPOSES HIGH PRE-OPERATIVE PLASMA FIBRINOGEN LEVELS AS AN INDEPENDENT NEGATIVE PROGNOSTIC FACTOR REGARDING CANCER-SPECIFIC, METASTASIS-FREE, AS WELL AS OVERALL SURVIVAL IN A EUROPEAN COHORT OF RENAL CELL CARCINOMA PATIENTS
J UROLOGY. 2013; 189(4): E300-E301. Doi: 10.1016/j.juro.2013.02.294 [Poster]
Web of Science FullText FullText_MUG

 

2012

Full paper/article (Journal)

** Barbieri, CE; Cha, EK; Chromecki, TF; Dunning, A; Lotan, Y; Svatek, RS; Scherr, DS; Karakiewicz, PI; Sun, M; Mazumdar, M; Shariat, SF Decision curve analysis assessing the clinical benefit of NMP22 in the detection of bladder cancer: secondary analysis of a prospective trial.
BJU Int. 2012; 109(5): 685-690. Doi: 10.1111/j.1464-410X.2011.010419.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Cha, EK; Shariat, SF; Kormaksson, M; Novara, G; Chromecki, TF; Scherr, DS; Lotan, Y; Raman, JD; Kassouf, W; Zigeuner, R; Remzi, M; Bensalah, K; Weizer, A; Kikuchi, E; Bolenz, C; Roscigno, M; Koppie, TM; Ng, CK; Fritsche, HM; Matsumoto, K; Walton, TJ; Ehdaie, B; Tritschler, S; Fajkovic, H; Martinez-Salamanca, JI; Pycha, A; Langner, C; Ficarra, V; Patard, JJ; Montorsi, F; Wood, CG; Karakiewicz, PI; Margulis, V Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Eur Urol. 2012; 61(4):818-825 Doi: 10.1016/j.eururo.2012.01.021
Web of Science PubMed FullText FullText_MUG

 

** Chromecki, TF; Cha, EK; Fajkovic, H; Margulis, V; Novara, G; Scherr, DS; Lotan, Y; Raman, JD; Kassouf, W; Bensalah, K; Weizer, A; Kikuchi, E; Roscigno, M; Remzi, M; Matsumoto, K; Walton, TJ; Pycha, A; Ficarra, V; Karakiewicz, PI; Zigeuner, R; Pummer, K; Shariat, SF The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy.
Eur Urol. 2012; 61(2): 245-253. Doi: 10.1016/j.eururo.2011.09.017
Web of Science PubMed FullText FullText_MUG

 

** Chromecki, TF; Cha, EK; Pummer, K; Scherr, DS; Tewari, AK; Sun, M; Fajkovic, H; Roehrborn, CG; Ashfaq, R; Karakiewicz, PI; Shariat, SF Prognostic value of insulin-like growth factor II mRNA binding protein 3 in patients treated with radical prostatectomy.
BJU Int. 2012; 110(1):63-68 Doi: 10.1111/j.1464-410X.2011.10703.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Chromecki, TF; Mauermann, J; Cha, EK; Svatek, RS; Fajkovic, H; Karakiewicz, PI; Lotan, Y; Tilki, D; Bastian, PJ; Volkmer, BG; Montorsi, F; Kassouf, W; Novara, G; Fritsche, HM; Ficarra, V; Stief, CG; Dinney, CP; Skinner, E; Pummer, K; Fradet, Y; Shariat, SF Multicenter validation of the prognostic value of patient age in patients treated with radical cystectomy.
World J Urol. 2012; 30(6):753-759 Doi: 10.1007/s00345-011-0772-2
Web of Science PubMed FullText FullText_MUG

 

** Fajkovic, H; Cha, EK; Jeldres, C; Donner, G; Chromecki, TF; Margulis, V; Novara, G; Lotan, Y; Raman, JD; Kassouf, W; Seitz, C; Bensalah, K; Weizer, A; Kikuchi, E; Roscigno, M; Remzi, M; Matsumoto, K; Breinl, E; Pycha, A; Ficarra, V; Montorsi, F; Karakiewicz, PI; Scherr, DS; Shariat, SF Prognostic value of extranodal extension and other lymph node parameters in patients with upper tract urothelial carcinoma.
J Urol. 2012; 187(3): 845-851. Doi: 10.1016/j.juro.2011.10.158
Web of Science PubMed FullText FullText_MUG

 

** Martinez-Salamanca, JI; Shariat, SF; Rodriguez, JC; Chromecki, TF; Ficarra, V; Fritsche, HM; Kassouf, W; Matsumoto, K; Cabello, LO; Seitz, C; Tritschler, S; Walton, TJ; Zattoni, F; Novara, G Prognostic role of ECOG performance status in patients with urothelial carcinoma of the upper urinary tract: an international study.
BJU Int. 2012; 109(8):1155-1161 Doi: 10.1111/j.1464-410X.2011.10479.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Hutterer, GC; Chromecki, TF; Jesche, J; Groselj-Strele, A; Kampel-Kettner, K; Pummer, K; Zigeuner, R Prognostic value of the Leibovich prognosis score supplemented by vascular invasion for clear cell renal cell carcinoma.
J Urol. 2012; 187(3):834-839 Doi: 10.1016/j.juro.2011.10.155
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Hutterer, GC; Chromecki, TF; Jesche, J; Kampel-Kettner, K; Eberhard, K; Hoefler, G; Pummer, K; Zigeuner, R Trends of stage, grade, histology and tumour necrosis in renal cell carcinoma in a European centre surgical series from 1984 to 2010.
J Clin Pathol. 2012; 65(8):721-724 Doi: 10.1136/jclinpath-2012-200797
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Hutterer, GC; Chromecki, TF; Jesche, J; Kampel-Kettner, K; Pummer, K; Zigeuner, R Renal cell carcinoma stage migration in a single European centre over 25 years: effects on 5- and 10-year metastasis-free survival.
Int Urol Nephrol. 2012; 44(4):997-1004 Doi: 10.1007/s11255-012-0165-5
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Hutterer, GC; Chromecki, TF; Jesche, J; Kampel-Kettner, K; Rehak, P; Pummer, K; Zigeuner, R Histologic tumor necrosis is an independent prognostic indicator for clear cell and papillary renal cell carcinoma.
Am J Clin Pathol. 2012; 137(2): 283-289. Doi: 10.1309/AJCPLBK9L9KDYQZP [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Rink, M; Chun, FK; Chromecki, TF; Fajkovic, H; Dahlem, R; Fisch, M; Shariat, SF Advanced bladder cancer in elderly patients : Prognostic outcomes and therapeutic strategies.
Urologe A. 2012; 51(6):820-828 Doi: 10.1007/s00120-011-2769-2
Web of Science PubMed FullText FullText_MUG

 

** Roscigno, M; Cha, EK; Rink, M; Seitz, C; Novara, G; Chromecki, TF; Fritsche, HM; Matsumoto, K; Walton, TJ; Carballido, J; Filippo Da Pozzo, L; Bertini, R; Ficarra, V; Otto, W; Karakiewicz, PI; Pycha, A; Fajkovic, H; Naspro, R; Scherr, DS; Montorsi, F; Shariat, SF International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvis.
BJU Int. 2012; 110(5):674-681 Doi: 10.1111/j.1464-410X.2012.10930.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Shariat, SF; Chromecki, TF; Cha, EK; Karakiewicz, PI; Sun, M; Fradet, Y; Isbarn, H; Scherr, DS; Bastian, PJ; Pummer, K; Fajkovic, H; Sagalowsky, AI; Ashfaq, R; Doblinger, M; Cote, RJ; Lotan, Y Risk stratification of organ confined bladder cancer after radical cystectomy using cell cycle related biomarkers.
J Urol. 2012; 187(2): 457-462. Doi: 10.1016/j.juro.2011.10.031
Web of Science PubMed FullText FullText_MUG

 

** Shariat, SF; Ehdaie, B; Rink, M; Cha, EK; Svatek, RS; Chromecki, TF; Fajkovic, H; Novara, G; David, SG; Daneshmand, S; Fradet, Y; Lotan, Y; Sagalowsky, AI; Clozel, T; Bastian, PJ; Kassouf, W; Fritsche, HM; Burger, M; Izawa, JI; Tilki, D; Abdollah, F; Chun, FK; Sonpavde, G; Karakiewicz, PI; Scherr, DS; Gonen, M Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment.
Eur Urol. 2012; 61(2): 237-242. Doi: 10.1016/j.eururo.2011.10.011 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Review

** Lee, DJ; Cha, EK; Dubin, JM; Beltran, H; Chromecki, TF; Fajkovic, H; Scherr, DS; Tagawa, ST; Shariat, SF Novel therapeutics for the management of castration-resistant prostate cancer (CRPC).
BJU Int. 2012; 109(7): 968-985. Doi: 10.1111/j.1464-410X.2011.10643.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Becker, A; Hansen, J; Eichelberg, C; Heuer, R; Meyer, CP; Adam, M; Kampel-Kettner, K; Kainz, MC; Chromecki, T; Jesche, J; Zigeuner, R; Chun, KHF A simplified 2 or 3 graded Fuhrman grading system for clear cell renal cell carcinoma could predict cancer-specific-survival as accurate as the traditional 4 graded system in patients from 2 tertiary care centers in Europe
EUR UROL SUPPL. 2012; 11(1): E1021-U136. [Poster]
Web of Science

 

** Brookman-May, S; May, M; Burger, M; Denzinger, S; Otto, W; Hoschke, B; Wieland, WF; Rossler, W; Wenzl, V; Kohlschreiber, S; Chromecki, T; Pahernik, S; Hohenfellner, M; Zigeuner, R Thrombocytosis is associated with a significant increase in cancer specific death rate after nephrectomy for patients with renal cell carcinoma
EUR UROL SUPPL. 2012; 11(1): E1019-U132. [Poster]
Web of Science

 

** Brookman-May, SD; May, M; Zigeuner, R; Chromecki, T; Shariat, SF; Burger, M; Wieland, WF; Cindolo, L; Wirth, MP; Pahernik, S; Zastrow, S Collecting system invasion and Fuhrman grading but not tumour size facilitate prognostic stratification of patients with pT2 renal cell carcinoma - can the current 7th edition of TNM classification be improved?
EUR UROL SUPPL. 2012; 11(1): E1015-U124. [Poster]
Web of Science

 

** Fajkovic, H; Cha, EK; Jeldres, C; Donner, G; Chromecki, TF; Margulis, V; Giacomo, N; Lotan, Y; Raman, JD; Kassouf, W; Seitz, C; Bensalah, K; Weizer, A; Kikuchi, E; Roscigno, M; Remzi, M; Matsumoto, K; Breinl, E; Pycha, A; Ficarra, V; Montorsi, F; Scherr, D; Shariat, SF. Prognostic value of extranodal extension and other lymph node parameters in patients with upper tract urothelial carcinoma
EUR UROL SUPPL. 2012; 11(1):E552-U189. [Oral Communication]
Web of Science

 

2011

Full paper/article (Journal)

** Brookman-May, S; May, M; Zigeuner, R; Shariat, SF; Scherr, DS; Chromecki, T; Moch, H; Wild, PJ; Mohamad-Al-Ali, B; Cindolo, L; Wieland, WF; Schips, L; De Cobelli, O; Rocco, B; Santoro, L; De Nunzio, C; Tubaro, A; Coman, I; Feciche, B; Truss, M; Dalpiaz, O; Hohenfellner, M; Gilfrich, C; Wirth, MP; Burger, M; Pahernik, S; CORONA Project (Collaborative Research on Renal Neoplasms Association) Collecting system invasion and Fuhrman grade but not tumor size facilitate prognostic stratification of patients with pT2 renal cell carcinoma.
J Urol. 2011; 186(6): 2175-2181. Doi: 10.1016/j.juro.2011.07.105
Web of Science PubMed FullText FullText_MUG

 

** Chromecki, TF; Ehdaie, B; Novara, G; Pummer, K; Zigeuner, R; Seitz, C; Pycha, A; Lee, RK; Cha, EK; Karakiewicz, PI; Ng, C; Raman, JD; Chun, FK; Fritsche, HM; Matsumoto, K; Kassouf, W; Walton, TJ; Bastian, PJ; Martnez-Salamanca, JI; Scherr, DS; Shariat, SF Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy.
WORLD J UROL. 2011; 29(4): 473-480. Doi: 10.1007/s00345-011-0677-0
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Ehdaie, B; Chromecki, TF; Lee, RK; Lotan, Y; Margulis, V; Karakiewicz, PI; Novara, G; Raman, JD; Ng, C; Lowrance, WT; Scherr, DS; Shariat, SF Obesity adversely impacts disease specific outcomes in patients with upper tract urothelial carcinoma.
J UROL. 2011; 186(1): 66-72. Doi: 10.1016/j.juro.2011.03.031 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Marszalek, M; Chromecki, T; Al-Ali, BM; Meixl, H; Madersbacher, S; Jeschke, K; Pummer, K; Zigeuner, R Laparoscopic partial nephrectomy: a matched-pair comparison of the transperitoneal versus the retroperitoneal approach.
Urology. 2011; 77(1): 109-113. Doi: 10.1016/j.urology.2010.02.057
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Matsushita, K; Cha, EK; Matsumoto, K; Baba, S; Chromecki, TF; Fajkovic, H; Sun, M; Karakiewicz, PI; Scherr, DS; Shariat, SF Immunohistochemical biomarkers for bladder cancer prognosis.
INT J UROL. 2011; 18(9): 616-629. Doi: 10.1111/j.1442-2042.2011.02809.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Hutterer, GC; Chromecki, TF; Jesche, J; Kampel-Kettner, K; Rehak, P; Pummer, K; Zigeuner, R External validation of the Leibovich prognosis score for nonmetastatic clear cell renal cell carcinoma at a single European center applying routine pathology.
J Urol. 2011; 186(5):1773-1777 Doi: 10.1016/j.juro.2011.07.034
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Shariat, SF; Chromecki, TF; Hoefer, J; Barbieri, CE; Scherr, DS; Karakiewicz, PI; Roehrborn, CG; Montorsi, F; Culig, Z; Cavarretta, IT Soluble gp130 regulates prostate cancer invasion and progression in an interleukin-6 dependent and independent manner.
J Urol. 2011; 186(5):2107-2114 Doi: 10.1016/j.juro.2011.06.048
Web of Science PubMed FullText FullText_MUG

 

** Shariat, SF; Savage, C; Chromecki, TF; Sun, M; Scherr, DS; Lee, RK; Lughezzani, G; Remzi, M; Marberger, MJ; Karakiewicz, PI; Vickers, AJ Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle-invasive bladder cancer and negative cytology: a decision-curve analysis.
CANCER-AM CANCER SOC. 2011; 117(13): 2892-2897. Doi: 10.1002/cncr.25903 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Short report/Letter

** Chromecki, TF; Cha, EK; Shariat, SF; Bladder Cancer Research Consortium Stage pT0 after radical cystectomy: are all patients equal?
EUR UROL. 2011; 60(3): 603-604. Doi: 10.1016/j.eururo.2011.05.050
Web of Science PubMed FullText FullText_MUG

 

Review

** Chromecki, TF; Bensalah, K; Remzi, M; Verhoest, G; Cha, EK; Scherr, DS; Novara, G; Karakiewicz, PI; Shariat, SF; Medscape Prognostic factors for upper urinary tract urothelial carcinoma.
NAT REV UROL. 2011; 8(8): 440-447. Doi: 10.1038/nrurol.2011.96
Web of Science PubMed FullText FullText_MUG

 

** Fajkovic, H; Halpern, JA; Cha, EK; Bahadori, A; Chromecki, TF; Karakiewicz, PI; Breinl, E; Merseburger, AS; Shariat, SF Impact of gender on bladder cancer incidence, staging, and prognosis.
WORLD J UROL. 2011; 29(4): 457-463. Doi: 10.1007/s00345-011-0709-9
Web of Science PubMed FullText FullText_MUG

 

** Verhoest, G; Shariat, SF; Chromecki, TF; Raman, JD; Margulis, V; Novara, G; Seitz, C; Remzi, M; Rouprêt, M; Scherr, DS; Bensalah, K Predictive factors of recurrence and survival of upper tract urothelial carcinomas.
World J Urol. 2011; 29(4):495-501 Doi: 10.1007/s00345-011-0710-3 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Journal)

** Chromecki, T; Cha, EK; Pummer, K; Shariat, SF CHRONOLOGICAL AGE IS NOT AN INDEPENDENT PREDICTOR OF CLINICAL OUTCOMES AFTER RADICAL NEPHROURETERECTOMY
J MENS HEALTH. . 2011; 8(3):216-217.-ISMH Congress 2011; Doi: 10.1016/j.jomh.2011.08.029 [Poster]
Web of Science FullText FullText_MUG

 

2010

Full paper/article (Journal)

** Zigeuner, R; Hutterer, G; Chromecki, T; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
Eur Urol. 2010; 57(1):102-9 Doi: 10.1016/j.eururo.2008.11.033
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2009

Full paper/article (Journal)

** Pristauz, G; Moinfar, F; Chromecki, T; Bader, AA; Winter, R; Tamussino, K Inflammatory myofibroblastic tumour of the urinary bladder mimicking recurrent uterine carcinosarcoma.
HISTOPATHOLOGY. 2009; 54(4): 490-493. Doi: 10.1111/j.1365-2559.2009.03253.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Journal)

** Chromecki, T; Hutterer, GC; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K; Zigeuner, R Stage migration of renal cell carcinoma in a European single centre over 23 years: Impact on survival
European Urology Supplements2009; 8(4):156-156.-24th Annual EAU Congress; MAR 17-21, 2009; Stockholm, SWEDEN. Doi: 10.1016/S1569-9056(09)60147-0 [Poster]
Web of Science FullText FullText_MUG

 

** Chromecki, T; Hutterer, GC; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K; Zigeuner, R The Leibovich - mayo clinic scoring algorithm for clear cell renal cell carcinoma supplemented by vascular invasion
European Urology Supplements2009; 8(4):154-154.-24th Annual EAU Congress; MAR 17-21, 2009; Stockholm, SWEDEN. Doi: 10.1016/S1569-9056(09)60141-X [Poster]
Web of Science FullText FullText_MUG

 

** Zigeuner, R; Hutterer, G; Chromecki, T; Rehak, P; Pummer, K Macroscopic versus microscopic vascular tumour invasion in patients with clear cell renal cell carcinoma: Does it make a difference?
J CLIN ONCOL. 2009; 27(15): 5093 - ASCO Annual Meeting; MAY 29-JUN 3, 2009; Orlando, FL, USA. [Poster]
Web of Science

 

2008

Full paper/article (Journal)

** Leibl, S; Zigeuner, R; Hutterer, G; Chromecki, T; Rehak, P; Langner, C EGFR expression in urothelial carcinoma of the upper urinary tract is associated with disease progression and metaplastic morphology.
APMIS. 2008; 116(1): 27-32. Doi: 10.1111/j.1600-0463.2008.00859.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Journal)

** Chromecki, T; Hutterer, G; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K; Zigeuner, R Sarcomatoid transformation and collecting system invasion: Independent prognostic indicators in patients with renal cell carcinoma?
EUR UROL SUPPL. 2008; 7(3):133-133.-23rd Annual EAU (European Association of Urology) Congress; MAR 26-29, 2008; Milan, Italy. Doi: 10.1016/S1569-9056(08)60248-1 [Poster]
Web of Science FullText FullText_MUG

 

** Chromecki, T; Hutterer, G; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K; Zigeuner, R Is the late occurrence of metastases associated with prolonged survival in renal cell carcinoma?
EUR UROL SUPPL. 2008; 7(3):260-260.-23rd Annual EAU (European Association of Urology) Congress; MAR 26-29, 2008; Milan, Italy. Doi: 10.1016/S1569-9056(08)60754-X [Poster]
Web of Science FullText FullText_MUG

 

** Hutterer, G; Chromecki, T; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K; Zigeuner, R Macrovascular vs. Microvascular tumour invasion in patients with renal cell carcinoma: Does it make a difference ?
EUR UROL SUPPL. EUROPEAN UROLOGY SUPPLEMENTS 2008; 7(3):134-134.-23rd Annual EAU (European Association of Urology) Congress; MAR 26-29, 2008; Milan, Italy. Doi: 10.1016/S1569-9056(08)60253-5 [Poster]
Web of Science FullText FullText_MUG

 

** Hutterer, G; Chromecki, T; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K; Zigeuner, R Tumour necrosis: An independent prognostic indicator for clear cell, as well as papillary renal cell carcinoma
EUR UROL SUPPL. 2008; 7(3):135-135.-23rd Annual EAU (European Association of Urology) Congress; MAR 26-29, 2008; Milan, Italy. Doi: 10.1016/S1569-9056(08)60258-4 [Poster]
Web of Science FullText FullText_MUG

 

** Karakiewicz, PI; Hutterer, GC; Suardi, N; Chromecki, T; Jeldres, C; Kampel-Kettner, K; Innamovic, A; Zigeuner, R; Bensaleh, K; Avakian, R; Shariat, SF; Montorsi, F; Perrotte, P; Patard, JJ Nomogram predicting renal cancer-specific survival in surgically treated patients with metastatic renal cell carcinoma
EUR UROL SUPPL. 2008; 7(3):282-282.-23rd Annual EAU (European Association of Urology) Congress; 26-29 March 2008; Milan, Italy. Doi: 10.1016/S1569-9056(08)60840-4 [Poster]
Web of Science FullText FullText_MUG

 

** Zigeuner, R; Hutterer, G; Chromecki, T; Kampel-Kettner, K; Imamovic, A; Langner, C; Rehak, P; Pummer, K The mayo clinic stage, size, grade and necrosis (SSIGN) score for clear cell renal cell carcinoma: External validation by a single European centre applying routine pathology
EUR UROL SUPPL. 2008; 7(3):280-280.-23rd Annual EAU (European Association of Urology) Congress; MAR 26-29, 2008; Milan, Italy. Doi: 10.1016/S1569-9056(08)60832-5 [Poster]
Web of Science FullText FullText_MUG

 

2007

Full paper/article (Journal)

** Winkler, A; Zigeuner, R; Rehak, P; Hutterer, G; Chromecki, T; Langner, C CD24 expression in urothelial carcinoma of the upper urinary tract correlates with tumour progression.
Virchows Arch. 2007; 450(1):59-64 Doi: 10.1007/s00428-006-0316-0
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Journal)

** Zigeuner, RE; Chromecki, T; Leibl, S; Rehak, P; Langner, C Desmoplasia is an independent prognostic indicator in urothelial carcinoma of the upper urinary tract
J UROL. 2007; 177(4):134-134.-AUA annual meeting; MAY 19-24, 2007; Anaheim, CA, USA. [Poster]
Web of Science

 

** Zigeuner, RE; Chromecki, T; Rehak, P; Langner, C Bladder tumor development after urothelial carcinoma of the upper urinary tract is related to primary tumor location
J UROL. 2007; 177(4):134-135.-AUA annual meeting; MAY 19-24, 2007; Anaheim, CA, USA. [Poster]
Web of Science

 

** Zigeuner, RE; Chromecki, T; Rehak, P; Langner, C Cox-2 expression in urothelial carcinomas of the upper urinary tract correlates with tumor progression
J UROL. 2007; 177(4):132-133.-AUA annual meeting; MAY 19-24, 2007; Anaheim, CA, USA. [Poster]
Web of Science

 

** Zigeuner, RE; Chromecki, T; Winkler, A; Rehak, P; Langner, C CD24 expression in urothelial carcinoma of the upper urinary tract correlates with tumor progression
J UROL. 2007; 177(4):132-132.-AUA annual meeting; MAY 19-24, 2007; Anaheim, CA, USA. [Poster]
Web of Science

 

2006

Full paper/article (Journal)

** Langner, C; Hutterer, G; Chromecki, T; Leibl, S; Rehak, P; Zigeuner, R Tumor necrosis as prognostic indicator in transitional cell carcinoma of the upper urinary tract.
J UROL. 2006; 176(3): 910-913. Doi: 10.1016/j.juro.2006.04.019
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Langner, C; Hutterer, G; Chromecki, T; Rehak, P; Zigeuner, R Patterns of invasion and histological growth as prognostic indicators in urothelial carcinoma of the upper urinary tract.
VIRCHOWS ARCHIV. 2006; 448(5): 604-611. Doi: 10.1007/s00428-006-0150-4
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Langner, C; Hutterer, G; Chromecki, T; Winkelmayer, I; Rehak, P; Zigeuner, R pT classification, grade, and vascular invasion as prognostic indicators in urothelial carcinoma of the upper urinary tract.
MODERN PATHOL. 2006; 19(2): 272-279. Doi: 10.1038/modpathol.3800529 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Langner, C; Rupar, G; Leibl, S; Hutterer, G; Chromecki, T; Hoefler, G; Rehak, P; Zigeuner, R Alpha-methylacyl-CoA racemase (AMACR/P504S) protein expression in urothelial carcinoma of the upper urinary tract correlates with tumour progression.
Virchows Arch. 2006; 448(3):325-330 Doi: 10.1007/s00428-005-0129-6
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Zigeuner, RE; Hutterer, G; Chromecki, T; Rehak, P; Langner, C Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location.
BJU Int. 2006; 98(6): 1181-1186. Doi: 10.1111/j.1464-410X.2006.06519.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Journal)

** Zigeuner, RE; Hutterer, G; Chromecki, T; Leibl, S; Rehak, P; Langner, C Impact of tumor stage, tumor grade, and vascular invasion on metastasis-free survival of patients with urothelial carcinoma of the upper urinary tract.
J UROL. ; 175: 352-352.-AUA Annual Meeting; May 20-25, 2006; Atlanta, Georgia. Doi: 10.1016/S0022-5347(18)33319-6 [Poster]
Web of Science FullText FullText_MUG

 

** Zigeuner, RE; Hutterer, G; Chromecki, T; Leibl, S; Rehak, P; Langner, C Tumor necrosis as prognostic indicator in urothelial carcinoma of the upper urinary tract.
J UROL. 175: 351-352.-AUA Annual Meeting; May 20-25, 2006; Atlanta, Georgia. Doi: 10.1016/S0022-5347(18)33318-4 [Poster]
Web of Science FullText FullText_MUG

 

** Zigeuner, RE; Leibl, S; Hutterer, G; Chromecki, T; Rehak, P; Langner, C Alpha-methylacyl-CoA racemase (AMACR/P504S) protein expression in urothelial carcinoma of the upper urinary tract correlates with tumour progression
J UROL. 2006; 175: 132-132.-AUA Annual Meeting; May 20-25, 2006; Atlanta, Georgia. Doi: 10.1016/S0022-5347(18)32661-2 [Poster]
Web of Science FullText FullText_MUG

 

** Zigeuner, RE; Leibl, S; Hutterer, G; Chromecki, T; Rehak, P; Langner, C EGFR expression in urothelial carcinoma of the upper urinary tract correlates with disease progression and metaplastic morphology
J UROL. ; 175: 239-239.-AUA Annual Meeting; May 20-25, 2006; Atlanta, Georgia. Doi: 10.1016/S0022-5347(18)32971-9 [Poster]
Web of Science FullText FullText_MUG

 

↑ Top of page / Navigation

© Med Uni Graz • Imprint